VS International

Mumbai, India Founded: 1997 • Age: 29 yrs Minicorn
Pharmaceutical products, healthcare items, and medical devices are manufactured.

About VS International

VS International is a Healthcare company based in Mumbai (India) founded in 1997. Pharmaceutical products, healthcare items, and medical devices are manufactured. VS International has raised $8.52 million across 2 funding rounds from investors including SIDBI Venture Capital, Ashit Harshad Vora and Vishal Harshad Vora. The company has 283 employees. VS International was last valued at $17.21 million in October 2022. Its Indian entity V S International Private Limited reported revenue of β‚Ή96.26 Cr. VS International offers products and services including Anti-Infectives, Cardiovascular, Oncology, and Endocrinology. Its focus areas include Biopharma Outsourcing, CDMO, Small Molecules & Peptides and Formulation.

Company details

VS International was founded in 1997 and is located in Mumbai, India. Operations focus on the pharmaceutical and healthcare sectors, where products and medical devices are manufactured, marketed, and exported. A manufacturing plant equipped with regulatory accreditations is maintained. Contract manufacturing services are offered to partners. In-house research and development facilities are utilized for product innovation and ongoing development.

  • Headquarters Mumbai, India
  • Employees 283
  • Stage Minicorn
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website vsinternational.co.in
  • Social LinkedIn Facebook
  • Legal Name V S International Private Limited
  • Date of Incorporation 25 Jul, 1997
  • Jurisdiction Mumbai, Maharashtra, India
Key Metrics
  • Annual Revenue
    ₹96.26 Cr

    FY 2024 · +65% YoY

  • Net Profit
    ₹2.76 Cr

    FY 2024 · 3% margin

  • EBITDA
    ₹10.97 Cr

    FY 2024 · 11% margin

  • Total Equity Funding
    $8.52M (USD)

    in 2 rounds

  • Latest Funding Round
    $1.81M (USD), Angel Round

    Oct 2022

  • Investors
  • Employee Count
    283

Products & Services of VS International

VS International offers a comprehensive portfolio of products and services, including Anti-Infectives, Cardiovascular, Oncology, and Endocrinology.

Anti-Infectives
Pharmaceuticals

Medications for treating bacterial and infectious diseases effectively.

Cardiovascular
Pharmaceuticals

Drugs aimed at managing heart and blood vessel conditions.

Oncology
Pharmaceuticals

Treatments for cancer to improve patient outcomes globally.

Endocrinology
Pharmaceuticals

Products for hormonal and metabolic disorder management.

Funding Insights of VS International

VS International has successfully raised a total of $8.52M across 2 strategic funding rounds. The most recent funding activity was a Angel Round of $1.81 million completed in October 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $8.52M
  • Total Rounds 2
  • Last Round Angel Round β€” $1.81M
  • First Round $6.71M

    (Dec 2006)

  • Investors Count 8

All 2 funding rounds of VS International with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Oct 2022$1.81MAngel Round$17.21MAshit Harshad Vora, Vishal Harshad Vora
Dec 2006$6.71MSeries A––
Valuation history
DateValuationStage
Oct 2022$17.21Mβ€’β€’β€’β€’β€’β€’β€’β€’

Last known valuation $17.21M (Oct 2022). 8 investors in total: 1 institutional and 7 angel.

Investors in VS International

VS International has secured backing from 8 investors, including angel and venture fund investors. Prominent investors backing the company include SIDBI Venture Capital, Ashit Harshad Vora and Vishal Harshad Vora.

All
Venture Fund
Angel
InvestorDescriptionFounded YearDomainLocation
Venture capital management for SMEs and startups in India.
1999sidbiventure.co.inMumbai, India

Ashit Harshad Vora

unknown_385506d8567f42688

Vishal Harshad Vora

unknown_2e7c56297262416bb

Anirudh Dilip Mehta

unknown_11cf5691a99745128

Dilip Sukhlal Mehta

unknown_3d8c61f9b631436c8

Ashit Harshad Vora

unknown_64181f352f33415bb

Anirudh Dilip Mehta

unknown_5db2a1ef0ff24ab2b

Dilip Sukhlal Mehta

unknown_de9e4617af814d13b
Premium access

Investor details for VS International

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Board of directors of V S International Private Limited (VS International)

V S International Private Limited is the primary company behind VS International. The board of V S International Private Limited currently have 5 directors; the longest-serving is Vidyut Dilip Shah, appointed in 1997. 2 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Vidyut Dilip Shah
DIN 00839227
Managing Director25 Jul 199729 yrs 3 moV S International Private Limited
Susie Vidyut Shah
DIN 00839369
Whole-time director25 Jul 199729 yrs 3 moV S International Private Limited
Purvesh Dilip Shah
DIN 00900226
Whole-time director01 Nov 200125 yrsV S International Private Limited
Radhika Vidyut Shah
DIN 07979099
Whole-time director16 Jan 20197 yrs 9 moV S International Private Limited
Aditya Vidyut Shah
DIN 07979098
Whole-time director16 Jan 20197 yrs 9 moV S International Private Limited

People of VS International

7 people are tracked at VS International (2 in leadership, 5 in team); the tracked headcount is 283.

NameRoleGroup
Managing DirectorLeadership
DirectorLeadership
Nikhil Shitut
ManagerTeam
Sejal Majithia
Manager- Sales & MarketingTeam
Neha Burra
Senior Procurement ExecutiveTeam
Sohan Bhandari
Sr.executiveTeam
Nayna Bhachhda
Product ExecutiveTeam
Premium access

Complete people profiles for VS International

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Financials of VS International

Figures of V S International Private Limited, the primary company behind VS International, for FY 2024. Revenue was ₹96.26 Cr (+65% year on year). Net profit was ₹2.76 Cr (3% margin). EBITDA was ₹10.97 Cr (11% margin). Revenue has grown at a compounded annual rate of +22% over three years and +19% over five years.

  • ₹96.26 CrRevenue · FY 2024 · +65% YoY
  • ₹2.76 CrNet profit · 3% margin
  • ₹10.97 CrEBITDA · 11% margin
  • ₹1.17 CrPaid-up capital
  • 283Employees (provident fund records)
  • +22%Revenue CAGR, 3 years
  • +19%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of V S International Private Limited are on its company page.

Premium access

Detailed financial statements for VS International

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Timeline of VS International

4 dated milestones of VS International across 25 years, from founding to its latest funding, stage changes and deals.

  1. Founded VS International is founded.
  2. Funding First funding round of $6.7M.
  3. Funding Latest funding round, Angel Round, of $1.8M.
  4. Milestone Reaches Minicorn status.

Web traffic of VS International

The website of VS International (vsinternational.co.in) receives about 1.4K visits a month.

  • Monthly visits
    1.4K

    ▲ 56.2% vs previous month

Top companies in Biopharma Outsourcing & Drug Delivery

3 companies that operate in the same segment as VS International (Biopharma Outsourcing & Drug Delivery) in India, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Developer of integrated contract research development and manufacturing services
2007Bengaluru, Karnataka, IndiaUSD 35.74 MUSD 226.38 M1,820
Pharmaceutical and biotechnology company
2005Hyderabad, Telangana, IndiaUSD 229.73 MUSD 726.15 M12,470
India's leading healthcare products distribution platform
2018Mumbai, Maharashtra, IndiaUSD 59.67 MUSD 702.49 M4,260
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about VS International

VS International was founded in 1997 and raised its 1st funding round 9 years after it was founded.

VS International is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.

VS International is a funded company, having raised a total of $8.52M across 2 funding rounds to date. The company's 1st funding round was a Series A of $6.71M, raised on Dec 2006.

VS International has 283 employees.

The primary company behind VS International, V S International Private Limited, reported revenue of β‚Ή96.26 Cr for FY 2024, up 65% year on year.

VS International was founded in 1997 and is located in Mumbai, India. Operations focus on the pharmaceutical and healthcare sectors, where products and medical devices are manufactured, marketed, and exported. A manufacturing plant equipped with regulatory accreditations is maintained. Contract manufacturing services are offered to partners. In-house research and development facilities are utilized for product innovation and ongoing development.

VS International offers Anti-Infectives, Cardiovascular, Oncology, and Endocrinology.

VS International has 8 investors. Key investors include SIDBI Venture Capital, Ashit Harshad Vora, Vishal Harshad Vora, Anirudh Dilip Mehta, and Dilip Sukhlal Mehta.

The valuation of VS International is $17.21M as of Oct 2022.

VS International operates through V S International Private Limited.

The legal entities of VS International currently have 5 directors, including Vidyut Dilip Shah, Susie Vidyut Shah, Radhika Vidyut Shah and others.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available